Table of Contents

company-logo

Innovation1 Biotech Inc., a drug discovery company, focuses on the development of modified schedule 1 molecules of botanical origin in the United States. Its portfolio includes five proprietary fully synthetic preclinical prodrugs addressing independent clinical indications comprising a mushroom-derived psychedelic molecule for treatment of post-traumatic stress disorder and depression; a novel cannabinoid and tree bark derived psychedelic for treatment of addiction; and three additional cannabinoid prodrugs addressing clinical indications of refractory pediatric epilepsy, hypertrophic scarring, and ocular inflammation. The company was formerly known as Gridiron BioNutrients, Inc. and changed its name to Innovation1 Biotech Inc. in March 2022. Innovation1 Biotech Inc. was founded in 2014 and is headquartered in New York, New York.

Innovation1 Biotech Dividend Announcement

• Innovation1 Biotech does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Innovation1 Biotech dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Innovation1 Biotech Dividend History

Innovation1 Biotech Dividend Yield

Innovation1 Biotech current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Innovation1 Biotech stock? Use our calculator to estimate your expected dividend yield:

Innovation1 Biotech Financial Ratios

P/E ratio-0.00
PEG ratio-0.00
P/B ratio-0.01
ROE436.45%
Payout ratio0.00%
Current ratio0.02
Quick ratio0.02
Cash Ratio0.02

Innovation1 Biotech Dividend FAQ

Does Innovation1 Biotech stock pay dividends?
Innovation1 Biotech does not currently pay dividends to its shareholders.
Has Innovation1 Biotech ever paid a dividend?
No, Innovation1 Biotech has no a history of paying dividends to its shareholders. Innovation1 Biotech is not known for its dividend payments.
Why doesn't Innovation1 Biotech pay dividends?
There are several potential reasons why Innovation1 Biotech would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Innovation1 Biotech ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Innovation1 Biotech has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Innovation1 Biotech a dividend aristocrat?
Innovation1 Biotech is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Innovation1 Biotech a dividend king?
Innovation1 Biotech is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Innovation1 Biotech a dividend stock?
No, Innovation1 Biotech is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Innovation1 Biotech stocks?
To buy Innovation1 Biotech you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Innovation1 Biotech stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.